Literature DB >> 8929175

Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection.

J Sánchez-Portocarrero1, E Pérez-Cecilia, A Jiménez-Escrig, P Martin-Rabadán, V Roca, M Ruiz Yague, J Romero-Vivas, E Palau, J J Picazo.   

Abstract

OBJECTIVE: To determine the prevalence and causes of meningitis in patients with human immunodeficiency virus (HIV) infection.
DESIGN: A prospective study of HIV-associated neurologic complications carried out from 1988 to 1992.
SETTING: A tertiary care university hospital in Madrid, Spain. PATIENTS. A total of 142 patients, 65% of whom were injecting drug users.
RESULTS: Thirty-six episodes of meningitis were diagnosed in 33 patients (23%). Of these, 17 cases (47%) were tuberculous meningitis (5 definite and 12 probable) and 7 (19%) corresponded to cryptococcal meningitis. Comparative studies of the tuberculous and cryptococcal meningitis cases showed injecting drug use as the most common form of HIV transmission in the tuberculous meningitis (P = .03) and a lower mean CD4+ cell count in the cryptococcal meningitis group (P = .02).
CONCLUSIONS: Tuberculous meningitis was the prime type of meningitis, which was associated with HIV transmission by injecting drug use. Cryptococcal meningitis appears in more advanced stages of HIV infection, which determines its characteristic presentation.

Entities:  

Mesh:

Year:  1996        PMID: 8929175     DOI: 10.1001/archneur.1996.00550070109018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

Review 1.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

Review 2.  Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients.

Authors:  Christina A Nelson; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2011-09-29       Impact factor: 9.079

3.  Is it possible to differentiate tuberculous and cryptococcal meningitis in HIV-infected patients using only clinical and basic cerebrospinal fluid characteristics?

Authors:  J E Vidal; E J F Peixoto de Miranda; J Gerhardt; M Croda; D R Boulware
Journal:  S Afr Med J       Date:  2017-01-30

4.  Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study.

Authors:  B Roca; N Tornador; E Tornador
Journal:  Epidemiol Infect       Date:  2008-01-21       Impact factor: 2.451

5.  Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis.

Authors:  I Corral; C Quereda; E Navas; P Martín-Dávila; M-J Pérez-Elías; J-L Casado; V Pintado; J Cobo; E Pallarés; J Rubí; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-13       Impact factor: 3.267

Review 6.  Tuberculous meningitis in HIV-infected individuals.

Authors:  Christopher Vinnard; Rob Roy Macgregor
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

7.  A Patient Presenting with Tuberculous Encephalopathy and Human Immunodeficiency Virus Infection.

Authors:  Jason Li; Suraiya Afroz; Eric French; Anuj Mehta
Journal:  Am J Case Rep       Date:  2016-06-15

Review 8.  Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis.

Authors:  Alba Navarro-Flores; Jose Ernesto Fernandez-Chinguel; Niels Pacheco-Barrios; David R Soriano-Moreno; Kevin Pacheco-Barrios
Journal:  J Neurol       Date:  2022-03-15       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.